Advertisement
Canada markets close in 4 hours 9 minutes
  • S&P/TSX

    24,175.64
    +103.13 (+0.43%)
     
  • S&P 500

    5,788.43
    +37.30 (+0.65%)
     
  • DOW

    42,463.28
    +382.91 (+0.91%)
     
  • CAD/USD

    0.7307
    -0.0022 (-0.30%)
     
  • CRUDE OIL

    73.32
    -0.25 (-0.34%)
     
  • Bitcoin CAD

    85,218.82
    +2.37 (+0.00%)
     
  • XRP CAD

    0.73
    +0.01 (+1.31%)
     
  • GOLD FUTURES

    2,633.50
    -1.90 (-0.07%)
     
  • RUSSELL 2000

    2,211.20
    +16.22 (+0.74%)
     
  • 10-Yr Bond

    4.0470
    +0.0140 (+0.35%)
     
  • NASDAQ

    18,287.21
    +104.29 (+0.57%)
     
  • VOLATILITY

    20.86
    -0.56 (-2.61%)
     
  • FTSE

    8,243.74
    +53.13 (+0.65%)
     
  • NIKKEI 225

    39,277.96
    +340.42 (+0.87%)
     
  • CAD/EUR

    0.6670
    -0.0002 (-0.03%)
     

Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study

April 18 (Reuters) - Cerevel Therapeutics said on Thursday its Parkinson's disease drug met the main goal of a late-stage trial. (Reporting by Sriparna Roy in Bengaluru; Editing by Savio D'Souza)